SG11202101098YA - Cell production method - Google Patents

Cell production method

Info

Publication number
SG11202101098YA
SG11202101098YA SG11202101098YA SG11202101098YA SG11202101098YA SG 11202101098Y A SG11202101098Y A SG 11202101098YA SG 11202101098Y A SG11202101098Y A SG 11202101098YA SG 11202101098Y A SG11202101098Y A SG 11202101098YA SG 11202101098Y A SG11202101098Y A SG 11202101098YA
Authority
SG
Singapore
Prior art keywords
production method
cell production
cell
production
Prior art date
Application number
SG11202101098YA
Inventor
Noriko Yamazoe
Hideyuki HIYOSHI
Taro Toyoda
Original Assignee
Univ Kyoto
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kyoto, Takeda Pharmaceuticals Co filed Critical Univ Kyoto
Publication of SG11202101098YA publication Critical patent/SG11202101098YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068General culture methods using substrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/16Activin; Inhibin; Mullerian inhibiting substance
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/33Insulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70Enzymes
    • C12N2501/72Transferases [EC 2.]
    • C12N2501/727Kinases (EC 2.7.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/003D culture

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG11202101098YA 2018-08-03 2019-08-02 Cell production method SG11202101098YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018146650 2018-08-03
PCT/JP2019/030437 WO2020027316A1 (en) 2018-08-03 2019-08-02 Cell production method

Publications (1)

Publication Number Publication Date
SG11202101098YA true SG11202101098YA (en) 2021-03-30

Family

ID=69230862

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202101098YA SG11202101098YA (en) 2018-08-03 2019-08-02 Cell production method

Country Status (10)

Country Link
US (1) US20210292708A1 (en)
EP (1) EP3831931A4 (en)
JP (1) JP7370600B2 (en)
CN (1) CN112912490B (en)
AU (1) AU2019313964A1 (en)
CA (1) CA3108679A1 (en)
IL (1) IL280556A (en)
SG (1) SG11202101098YA (en)
TW (1) TW202014514A (en)
WO (1) WO2020027316A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3587560A4 (en) * 2017-01-27 2020-12-16 Kaneka Corporation Endodermal cell mass, and method for producing any one of three primary germ layer cell mass from pluripotent cells
EP4249587A1 (en) * 2020-11-20 2023-09-27 Orizuru Therapeutics, Inc. Maturation agent
CN114807013B (en) * 2022-04-25 2023-11-17 宫念樵 Method for differentiating peripheral blood stem cells into endoderm cells and application thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1610642T3 (en) 2004-04-10 2007-01-31 Henkel Kgaa Hair roller
US8048999B2 (en) 2005-12-13 2011-11-01 Kyoto University Nuclear reprogramming factor
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US8741643B2 (en) * 2006-04-28 2014-06-03 Lifescan, Inc. Differentiation of pluripotent stem cells to definitive endoderm lineage
US7661738B2 (en) 2006-11-28 2010-02-16 Veritainer Corporation Radiation detection unit for mounting a radiation sensor to a container crane
JP2010523117A (en) 2007-04-07 2010-07-15 ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ Somatic cell reprogramming
JP2010528622A (en) 2007-05-30 2010-08-26 ザ ジェネラル ホスピタル コーポレイション Methods for generating pluripotent cells from somatic cells
JP2008307007A (en) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag Human pluripotent stem cell induced from human tissue-originated undifferentiated stem cell after birth
CA2693156C (en) 2007-07-18 2018-03-06 Alireza Rezania Differentiation of human embryonic stem cells
EP2356227B1 (en) 2008-11-14 2018-03-28 Viacyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
PL2611910T3 (en) 2010-08-31 2018-06-29 Janssen Biotech, Inc Differentiation of human embryonic stem cells
CA3212301A1 (en) * 2013-02-06 2014-08-14 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
JP6232638B2 (en) 2013-06-24 2017-11-22 国立研究開発法人医薬基盤・健康・栄養研究所 Hepatic progenitor cell growth medium
GB201317869D0 (en) * 2013-10-09 2013-11-20 Cambridge Entpr Ltd In vitro production of foregut stem cells
CA2957000C (en) 2014-08-04 2023-08-01 Takeda Pharmaceutical Company Limited Method for proliferation of pancreatic progenitor cells
JP7209619B2 (en) 2016-07-28 2023-01-20 エフ.ホフマン-ラ ロシュ アーゲー Non-human primate induced pluripotent stem cell-derived hepatocytes and uses thereof
JP6932947B2 (en) 2017-03-02 2021-09-08 コニカミノルタ株式会社 Defective image occurrence prediction system and defective image occurrence prediction program
BR112021004815A2 (en) * 2018-09-19 2021-06-01 Takeda Pharmaceutical Company Limited insulin-producing cells, medicine, and, methods of producing insulin-producing cells, to generate pancreatic islet-like cells, to treat diabetes mellitus, to improve and/or maintain control of fasting and postprandial glucose levels in a patient and to reduce the risk of hypoglycaemia in a patient with diabetes mellitus

Also Published As

Publication number Publication date
JP7370600B2 (en) 2023-10-30
TW202014514A (en) 2020-04-16
EP3831931A4 (en) 2022-05-18
IL280556A (en) 2021-03-25
CA3108679A1 (en) 2020-02-06
CN112912490B (en) 2023-12-26
US20210292708A1 (en) 2021-09-23
AU2019313964A1 (en) 2021-03-18
WO2020027316A1 (en) 2020-02-06
EP3831931A1 (en) 2021-06-09
CN112912490A (en) 2021-06-04
JPWO2020027316A1 (en) 2021-08-02

Similar Documents

Publication Publication Date Title
IL276600A (en) Methods for manufacturing t cells
IL276597A (en) Method for producing low-antigenic cell
EP3312846A4 (en) Solid electrolyte production method
EP3712967C0 (en) Method for manufacturing solar cell
HUE064016T2 (en) Method for producing lgps-based solid electrolyte
PL3809425T3 (en) Lgps-based solid electrolyte and production method
HUE056390T2 (en) Production method for solid electrolyte having li3ps4
EP3312847A4 (en) Solid electrolyte production method
GB201707143D0 (en) Method for producing cells
HUE054696T2 (en) Production method for lgps-based solid electrolyte
EP3518322A4 (en) Production method for film-clad battery
EP3598462A4 (en) Method for producing solid electrolyte
EP3751001C0 (en) Ergothioneine production method
PL3699996T3 (en) Production method for all-solid-state battery
IL280556A (en) Cell production method
EP3778902A4 (en) Cell production method
PL3942107T3 (en) Production method
SG11202004021RA (en) Production method for dihydroxyindoles
IL283085A (en) Improved t cell manufacturing process
EP3663343A4 (en) Porous-object production method
EP3587563A4 (en) Nerve cell production method
EP3896155A4 (en) Production method for genome-edited cells
EP3808839A4 (en) Transformed cell production method
EP3780216A4 (en) Battery production method
EP3719133A4 (en) Method for producing neural cells